Flagging new reanalysis candidates from Exomiser score changes across database releases (Vestito et al. 2024 Supplementary Table 1)
Variant-level classification of Exomiser candidates flagged by a human phenotype score increase and a variant score threshold, against the later diagnoses.
Overview
Variant-level classification of Exomiser candidates flagged by a human phenotype score increase and a variant score threshold, against the later diagnoses.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
81 recorded evaluations, 648 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
81 evaluations · 648 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
Source checking is not independent reproduction. Release 2026-10-10-7fcc3e48a123.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
- Exomiser reanalysis flag 0.1/0.1: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.2: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.3: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.4: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.5: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.6: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.7: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.8: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.1/0.9: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.2/0.1: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.2/0.2: later-diagnosed 100kGP cases
- Exomiser reanalysis flag 0.2/0.3: later-diagnosed 100kGP cases
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 81
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Training-set class prior where supervised fitting is permitted
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Regularised classifier on simple permitted features, or protocol's conventional reference
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-10-10-7fcc3e48a123. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-10-7fcc3e48a123 · Record review: source checked
2 source records and release history
- Efficient reinterpretation of rare disease cases using Exomiser · Original source · npj Genomic Medicine 9:65, published 2024-12-18; PMC11655964 full-text XML
- Vestito et al. 2024, Supplementary Table 1 · Original source · 41525_2024_456_MOESM1_ESM.pdf from the Europe PMC supplementary bundle (PDF title 'Supplementary_table_S1 copy', 4 pages)
Technical metadata and extraction receipts
Stable ID: rare-reanalysis-20261009-protocol-vestito2024-new-candidate-flagging
- areas
- dna-genomes
- contexts
- clinical_research
- protocol
- Exomiser 13.1.0 run on the 37 cases with database releases from February 2019 to February 2022. A variant is flagged when its human phenotype score increases by at least the stated difference between runs and its variant score exceeds the stated threshold. Each Exomiser variant is classified TP, FN, FP or TN against the diagnosed variants; recall, precision, F and F2 are derived in R 4.2.1. Fewer false positives means fewer candidates to review.
- version
- Supplementary Table 1
- denominator
- 37
- source locator
- Results paragraphs 5-6; Methods 'Reanalysis optimisation'; Supplementary Table 1
- limitations
- Retrospective: the 37 cases were already diagnosed, so this measures recovery of known later diagnoses, not new diagnostic yield.; The database releases compared are not printed in the supplement; the row for 0.2 and 0.8 matches the text's February 2019 versus February 2022 comparison (claim).; Run by the Exomiser developers.; The ACMG/AMP classifier condition reported in the text (precision 88%, recall 82%) is not in this table.
- missing metadata
- uncertainty: reason: unreported
Related records
- uses data: 100,000 Genomes Project: 37 cases unsolved in February 2019 and later diagnosed through a new disease-gene association (Vestito et al. 2024)
- subject: compared_database_releases: rare-reanalysis-20261009-protocol-vestito2024-new-candidate-flagging
- subject: candidates_to_review: rare-reanalysis-20261009-protocol-vestito2024-new-candidate-flagging
- assessment: Exomiser reanalysis flag 0.1/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.1/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.2/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.3/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.4/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.5/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.6/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.7/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.8/0.9: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.1: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.2: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.3: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.4: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.5: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.6: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.7: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.8: later-diagnosed 100kGP cases
- assessment: Exomiser reanalysis flag 0.9/0.9: later-diagnosed 100kGP cases
- assessed by: Reanalyse unresolved rare-disease cases